A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging

Biomaterials

Volumn 31, Issue 25, 2010, Pages 6612-6617

  Zhang, Chao ^a   Liu, Tao ^a   Su, Yongping ^a   Luo, Shenglin ^a   Zhu, Ying ^a   Tan, Xu ^a   Fan, Song ^a   Zhang, Lilong ^a   Zhou, Yue ^a   Cheng, Tianmin ^a   Shi, Chunmeng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Fluorescence; Heptamethine dye; In vivo test; Tumor targeting

Indexed keywords

C57BL/6 MICE; CYANINE DYES; DYE ACCUMULATION; FLUORESCENT PROBES; FLUORESCENT REPORTER; FLUORESCENT SIGNALS; IN-VIVO IMAGING; IN-VIVO TESTS; INDOCYANINE; LUNG TUMOR; MITOCHONDRIAL MEMBRANE POTENTIAL; NEAR INFRARED; NEAR-INFRARED FLUORESCENCE; NUDE MICE; ORGANIC ANIONS; TISSUE AUTOFLUORESCENCE; TUMOR ACCUMULATION; TUMOR CELLS; TUMOR DETECTION; TUMOR IMAGING; TUMOR TARGETING; TUMOR XENOGRAFTS;

CELL MEMBRANES; FLUORESCENCE; INFRARED DEVICES;

TUMORS;

2 [2 [2 CHLORO 3 [(1,3 DIHYDRO 3,3 DIMETHYL 1 PROPYL 2H INDOL 2 YLIDENE)ETHYLIDENE] 1 CYCLOHEXEN 1 YL]ETHENYL] 3,3 DIMETHYL 1 PROPYLINDOLIUM IODIDE; BROMSULFOPHTHALEIN; DIAGNOSTIC AGENT; FLUORESCENT DYE; IR 780; ORGANIC ANION TRANSPORTER; UNCLASSIFIED DRUG; 2-(2-(2-CHLORO-3-((1,3-DIHYDRO-3,3-DIMETHYL-1-PROPYL-2H-INDOL-2-YLIDENE)ETHYLIDENE)-1-CYCLOHEXEN-1-YL)ETHENYL)-3,3-DIMETHYL-1-PROPYLINDOLIUM; INDOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG TRANSPORT; EXPERIMENTAL NEOPLASM; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; LUNG TUMOR; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NEAR INFRARED FLUORESCENCE IMAGING; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR CELL; TUMOR DIAGNOSIS; TUMOR XENOGRAFT; ANIMAL; C57BL MOUSE; CHEMISTRY; DIAGNOSTIC USE; FLUORESCENCE; LUNG NEOPLASMS; NEAR INFRARED SPECTROSCOPY; NEOPLASMS; PROCEDURES; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; FLUORESCENCE; FLUORESCENT DYES; HUMANS; INDOLES; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASMS; SPECTROSCOPY, NEAR-INFRARED;

MUS; MUS MUSCULUS;

EID: 77953957735     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.05.007     Document Type: Article

References (28)

1. Ntziachristos V., Bremer C., Weissleder R. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 2003, 13(1):195-208.
2. Frangioni J.V. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 2003, 7(5):626-634.
3. Xu R.X., Young D.C., Mao J.J., Povoski S.P. A prospective pilot clinical trial evaluating the utility of a dynamic near-infrared imaging device for characterizing suspicious breast lesions. Breast Cancer Res 2007, 9(6):R88.
4. Tromberg B.J., Pogue B.W., Paulsen K.D., Yodh A.G., Boas D.A., Cerussi A.E. Assessing the future of diffuse optical imaging technologies for breast cancer management. Med Phys 2008, 35(6):2443-2451.
5. Rao J., Dragulescu-Andrasi A., Yao H. Fluorescence imaging in vivo: recent advances. Curr Opin Biotechnol 2007, 18(1):17-25.
6. Ogawa M., Kosaka N., Choyke P.L., Kobayashi H. In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. Cancer Res 2009, 69(4):1268-1272.
7. Tsujino Y., Mizumoto K., Matsuzaka Y., Niihara H., Morita E. Fluorescence navigation with indocyanine green for detecting sentinel nodes in extramammary Paget's disease and squamous cell carcinoma. J Dermatol 2009, 36(2):90-94.
8. Nakayama A., Bianco A.C., Zhang C.Y., Lowell B.B., Frangioni J.V. Quantitation of brown adipose tissue perfusion in transgenic mice using near-infrared fluorescence imaging. Mol Imaging 2003, 2(1):37-49.
9. Andreev O.A., Dupuy A.D., Segala M., Sandugu S., Serra D.A., Chichester C.O., et al. Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo. Proc Natl Acad Sci U S A 2007, 104(19):7893-7898.
10. Kumar S., Richards-Kortum R. Optical molecular imaging agents for cancer diagnostics and therapeutics. Nanomedicine (Lond) 2006, 1(1):23-30.
11. Achilefu S. Lighting up tumors with receptor-specific optical molecular probes. Technol Cancer Res Treat 2004, 3(4):393-409.
12. Wang X., Yang L., Chen Z.G., Shin D.M. Application of nanotechnology in cancer therapy and imaging. CA Cancer J Clin 2008, 58(2):97-110.
13. Zhang C., Wang S., Xiao J., Tan X., Zhu Y., Su Y., et al. Sentinel lymph node mapping by a near-infrared fluorescent heptamethine dye. Biomaterials 2010, 31(7):1911-1917.
14. Schuller H.M. Nitrosamines as nicotinic receptor ligands. Life Sci 2007, 80(24-25):2274-2280.
15. Monfared A., Blevins N.H., Cheung E.L., Jung J.C., Popelka G., Schnitzer M.J. In vivo imaging of mammalian cochlear blood flow using fluorescence microendoscopy. Otol Neurotol 2006, 27(2):144-152.
16. Davis S., Weiss M.J., Wong J.R., Lampidis T.J., Chen L.B. Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J Biol Chem 1985, 260(25):13844-13850.
17. Modica-Napolitano J.S., Aprille J.R. Basis for the selective cytotoxicity of rhodamine 123. Cancer Res 1987, 47(16):4361-4365.
18. Dietzen D.J., Davis E.J. Excess membrane cholesterol is not responsible for metabolic and bioenergetic changes in AS-30D hepatoma mitochondria. Arch Biochem Biophys 1994, 309(2):341-347.
19. Trivedi E.R., Harney A.S., Olive M.B., Podgorski I., Moin K., Sloane B.F., et al. Chiral porphyrazine near-IR optical imaging agent exhibiting preferential tumor accumulation. Proc Natl Acad Sci U S A 2010, 107(4):1284-1288.
20. Hagenbuch B., Scharschmidt B.F., Meier P.J. Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes. Biochem J 1996, 316(Pt 3):901-904.
21. Sakamoto K., Mikami H., Kimura J. Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres. Br J Pharmacol 2008, 154(7):1482-1490.
22. Dilda P.J., Decollogne S., Weerakoon L., Norris M.D., Haber M., Allen J.D., et al. Optimization of the antitumor efficacy of a synthetic mitochondrial toxin by increasing the residence time in the cytosol. J Med Chem 2009, 52(20):6209-6216.
23. De Grand A.M., Frangioni J.V. An operational near-infrared fluorescence imaging system prototype for large animal surgery. Technol Cancer Res Treat 2003, 2(6):553-562.
24. Li C., Greenwood T.R., Glunde K. Glucosamine-bound near-infrared fluorescent probes with lysosomal specificity for breast tumor imaging. Neoplasia 2008, 10(4):389-398.
25. Murphy M.P. Targeting lipophilic cations to mitochondria. Biochim Biophys Acta 2008, 1777(7-8):1028-1031.
26. Modica-Napolitano J.S., Aprille J.R. Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells. Adv Drug Deliv Rev 2001, 49(1-2):63-70.
27. Al Sarakbi W., Mokbel R., Salhab M., Jiang W.G., Reed M.J., Mokbel K. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer. Anticancer Res 2006, 26(6C):4985-4990.
28. Anderson W.M., Chambers B.B., Wood J.M., Benninger L. Inhibitory effects of two structurally related carbocyanine laser dyes on the activity of bovine heart mitochondrial and Paracoccus denitrificans NADH-ubiquinone reductase. Evidence for a rotenone-type mechanism. Biochem Pharmacol 1991, 41(5):677-684.